Comez, Mehmet Selim2024-09-192024-09-192020978-153617848-7978-153617847-0https://hdl.handle.net/20.500.12483/15486Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause. The first guideline on IPF management, published in 2000, is based on the consensus of an international group of experts in the field. The guideline, created by hard work by the American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and Latin American Thoracic Society (ALAT) in 2011, reviewed all available evidence, clarified the definition of IPF, provided precise diagnostic criteria, described the natural course of the disease, and provided evidence-based recommendations for treatment. In 2015, recommendations for the treatment of IPF were updated on the basis of new scientific evidence. No pharmacological intervention has received strong recommendations for treatment. Clinicians should make individualized decisions based on conditional recommendations in the treatment of patients with IPF. © 2020 Nova Science Publishers, Inc.eninfo:eu-repo/semantics/closedAccessBook Chapter3954052-s2.0-85144501267N/A